Overview

Continuous Renal Replacement Therapy Market is estimated to register a CAGR of 7.3% during the forecast period 2022 to 2028.

Rising prevalence of congestive heart failure and acute renal failure is the prime factor driving the market growth. According to the data provided by the New England Journal of Medicine, 2009, acute kidney injury has over 55% of mortality rate, resulting in the usage of renal replacement therapy. Continuous renal replacement therapy (CRRT) is primarily used for treating AKI patients that are hemodynamically unstable as it offers efficient removal of solute and a better hemodynamic stability when compared to other techniques of dialysis.

According to the data provided by Baxter,2015 the number of AKI patients across the world is predicted to reach over 1.6 million by 2020 from over 790,000 cases in 2009. Furthermore, as per the annual report of NxStage, 2013, over 190,000 acute kidney failure cases are registered in the United States alone. Moreover, as per the International Society of Nephrology, over 10% of patients hospitalised in the European Union have developed AKI with a high mortality rate. Such a high risk of AKI has significantly increased the continuous renal replacement therapy market demand. However, the high cost of CRRT is predicted to impede the market growth

Market Segmentation:

By Product

Dialysates & Replacement Fluids
Systems
Disposables

By Modality

Continuous Veno-Venous Hemofiltration
Continuous Veno-Venous Hemodiafiltration
Continuous Veno-Venous Hemodialysis
Slow Continuous Ultrafiltration

By Therapy

Renal Care
Non-Renal Care

By End User

Hospitals
Dialysis Centers
Others

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

The market is classified into product, modality, therapy, end user and region. The product segment is categorised into dialysates and replacement fluids, systems and disposables. The replacement fluids and dialysates is anticipated to hold the largest continuous renal replacement therapy market share and this can be attributed to the rising need of these products during the CRRT processes along with technological advancements. The modality segment is divided into continuous veno-venous hemodiafiltration, continuous veno-venous hemofiltration, slow continuous ultrafiltration and continuous veno-venous haemodialysis. The CVVH segment is predicted to lead the market during the forecasted period owing to the higher acceptance of this modality amongst healthcare service providers due to the benefits offer by CCRT modalities.

Regional Analysis:

The Europe region is predicted to subjugate the market during the forecasted timeframe and this can credited to rising prevalence of AKI owing to the increasing geriatric population, high usage rate of this procedure and rising approvals for CRRT systems shall drive the market growth.

Competitive Landscape:

Some of the major players of the market are Baxter International Inc., Fresenius Medical Care AG & Co. KGAA, Nikkiso Co. Ltd., B. Braun, Nxstage Medical Inc., Asahi Kasei Medical Co. Ltd, Bellco S.R.L., Infomed SA.

FutureWise Key Takeaways:

Growth prospects
SWOT analysis
Key market trends
Key data-points affecting market growth

Objectives of the Study:

To provide with an exhaustive analysis on the global continuous renal replacement therapy market by product, by modality, by therapy, by end user and by region
To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
To evaluate and forecast micro-markets and the overall market
To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
The customization Mobility Care offered are free of charge with purchase of any license of the report
You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com